Granules India quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	1,477	1,210	+22.0%
EBITDA	339	247	+37.4%
EBITDA margin	23.0%	20.4%	+2.6 pts
Profit before tax	240	145	+66.3%
Net profit	180	113	+59.8%
EPS	₹7.26	₹4.64	+56.5%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	1,477	1,471	1,388	1,297	1,210	1,197	1,138	967	1,180	1,176	1,156	1,189	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	2.3	8.8	−3.6	−1.1	16.3	1.9	5.7	3.3	2.1	1.9	0.7	1.5
	1,479	1,479	1,384	1,296	1,226	1,199	1,143	970	1,182	1,178	1,156	1,191
	496	644	529	498	429	435	445	362	483	547	553	520
	12.0	−140	−27.7	−52.8	−3.4	3.7	−9.1	4.8	1.4	−76.9	−55.9	55.4
	255	240	226	219	203	169	168	159	164	152	157	149
	21.1	32.7	28.7	29.2	23.8	24.0	26.6	25.7	27.0	28.8	28.6	26.0
	79.6	81.7	73.5	72.0	68.8	63.5	56.6	52.5	52.9	53.2	52.4	52.5
	375	374	352	355	336	338	304	237	273	299	251	253
	1,239	1,233	1,182	1,120	1,056	1,033	991	841	1,000	1,002	986	1,055
	339	352	308	278	247	252	230	203	259	256	250	213
	259	270	235	206	178	189	174	151	206	203	198	160
Profit
	240	246	202	176	170	167	153	128	181	176	170	136
	0.0	15.9	0.0	0.0	−25.9	30.8	0.0	0.0	0.0	0.0	0.0	0.0
	240	262	202	176	145	198	153	128	181	176	170	136
	64.6	34.3	72.9	50.8	38.1	61.8	36.9	31.3	52.8	49.3	54.1	36.2
	−4.1	26.5	−20.9	−5.6	−6.2	−16.3	−1.8	−0.1	−6.0	−3.3	−9.6	−2.3
	60.4	60.8	52.0	45.3	31.9	45.5	35.2	31.1	46.8	46.0	44.4	33.9
	180	202	150	131	113	152	118	97.2	135	130	126	102
	180	202	150	131	113	152	118	97.2	135	130	126	102
	30.1	66.2	18.6	39.5	19.0	10.6	10.4	3.7	2.4	9.4	−4.5	15.6
	210	268	169	170	132	163	128	101	137	139	121	118
	180	—	150	131	110	152	118	97.2	135	139	126	—
Per share
	₹7.26	₹8.23	₹6.19	₹5.38	₹4.64	₹6.27	₹4.85	₹4.01	₹5.56	₹5.35	₹5.18	₹4.22
	₹7.12	₹8.23	₹6.19	₹5.38	₹4.64	₹6.27	₹4.85	₹4.01	₹5.55	₹5.35	₹5.18	₹4.22
Other comprehensive income — detail
	30.1	66.2	18.6	39.5	19.0	10.6	—	—	—	—	—	—
	—	10.3	—	—	—	2.1	—	—	—	−0.6	—	—
	—	2.1	—	—	—	0.5	—	—	—	—	—	—
	—	—	—	—	—	—	—	—	—	−0.1	—	—
	38.1	49.6	17.9	36.4	18.7	13.1	6.7	3.4	3.1	12.5	−6.4	17.5
	8.0	−8.4	−0.7	−3.1	−0.3	4.0	—	—	—	—	—	—
	—	—	—	—	—	—	−3.7	−0.3	0.8	2.7	−1.9	2.0
	210	—	169	170	—	163	128	101	137	—	121	118
Per share — as-filed variants
	₹7.26	₹8.23	₹6.19	₹5.38	₹4.64	₹6.27	₹4.85	₹4.01	₹5.56	₹5.35	₹5.18	₹4.22
	₹7.12	₹8.23	₹6.19	₹5.38	₹4.64	₹6.27	₹4.85	₹4.01	₹5.55	₹5.35	₹5.18	₹4.22
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	969	966	886	852	785	759	702	599	695	706	658	614
	65.6%	65.7%	63.9%	65.7%	64.9%	63.4%	61.7%	62.0%	58.9%	60.1%	57.0%	51.7%
Adjusted (ex-exceptional items) — derived
	240	246	202	176	170	167	153	128	181	176	170	136
	0.0	15.9	0.0	0.0	−25.9	30.8	0.0	0.0	0.0	0.0	0.0	0.0
	180	189	150	131	133	128	118	97.2	135	130	126	102
	₹7.26	₹7.73	₹6.19	₹5.38	₹5.47	₹5.29	₹4.85	₹4.01	₹5.56	₹5.35	₹5.18	₹4.22

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GRANULES₹840.45

Granules India Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersAUROPHARMA IPCALAB AARTIDRUGS ERIS INDGN EMCURE JUBLPHARMA CONCORDBIOMcap ₹20,826 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	1,189.5	1,155.6	1,175.8	1,179.9	966.6	1,137.7	1,197.4	1,210.1	1,297.0	1,387.9	1,470.6	1,476.8
Other Income	1.5	0.7	1.9	2.1	3.3	5.7	1.9	16.3	-1.1	-3.6	8.8	2.3
Total Income	1,191.0	1,156.2	1,177.7	1,181.9	969.9	1,143.4	1,199.4	1,226.5	1,295.8	1,384.3	1,479.4	1,479.0
Expenses
+ Cost of Materials Consumed	519.8	553.3	546.5	483.0	362.5	444.8	434.7	428.5	497.8	529.2	644.2	495.8
+ Changes in Inventories	55.4	-55.9	-76.9	1.4	4.8	-9.1	3.7	-3.4	-52.8	-27.7	-140.1	12.0
+ Employee Benefit Expense	148.8	157.0	151.7	163.6	159.4	167.6	169.1	202.8	219.2	226.0	240.4	254.6
+ Finance Costs	26.0	28.6	28.8	27.0	25.7	26.6	24.0	23.8	29.2	28.7	32.7	21.1
+ Depreciation & Amortisation	52.5	52.4	53.2	52.9	52.5	56.6	63.5	68.8	72.0	73.5	81.7	79.6
+ Other Expenses	252.6	250.8	298.8	272.5	236.7	304.1	337.6	335.6	354.6	352.3	373.9	375.5
Total Expenses	1,055.0	986.1	1,002.0	1,000.5	841.5	990.6	1,032.6	1,056.0	1,120.0	1,182.1	1,232.9	1,238.6
EBITDA	213.0	250.5	255.7	259.3	203.3	230.3	252.4	246.7	278.2	308.1	352.1	338.9
EBIT	160.5	198.1	202.5	206.4	150.8	173.7	188.9	177.9	206.2	234.6	270.4	259.3
Profit
PBT before Exceptional Items	136.0	170.1	175.6	181.4	128.4	152.8	166.8	170.4	175.9	202.2	246.4	240.4
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.0	30.8	-25.9	0.0	0.0	15.9	0.0
Pretax Income	136.0	170.1	175.6	181.4	128.4	152.8	197.6	144.5	175.9	202.2	262.4	240.4
+ Current Tax	36.2	54.1	49.3	52.8	31.3	36.9	61.8	38.1	50.8	72.9	34.3	64.6
+ Deferred Tax	-2.3	-9.6	-3.3	-6.0	-0.1	-1.8	-16.3	-6.2	-5.6	-20.9	26.5	-4.1
Tax Expense	33.9	44.4	46.0	46.8	31.1	35.2	45.5	31.9	45.3	52.0	60.8	60.4
Net Income	102.1	125.7	129.6	134.6	97.2	117.6	152.0	112.6	130.6	150.2	201.6	180.0
+ Net Income — Continuing Ops	102.1	125.7	129.6	134.6	97.2	117.6	152.0	112.6	130.6	150.2	201.6	180.0
+ Other Comprehensive Income	15.6	-4.5	9.4	2.4	3.7	10.4	10.6	19.0	39.5	18.6	66.2	30.1
Total Comprehensive Income	117.7	121.1	139.0	137.0	100.9	128.0	162.6	131.7	170.1	168.8	267.8	210.0
Net Income to Common	—	125.7	139.0	134.6	97.2	117.6	152.0	110.4	130.6	150.2	—	180.0
Per Share
Basic EPS	4.22	5.18	5.35	5.56	4.01	4.85	6.27	4.64	5.38	6.19	8.23	7.26
Diluted EPS	4.22	5.18	5.35	5.55	4.01	4.85	6.27	4.64	5.38	6.19	8.23	7.12
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	10.6	19.0	39.5	18.6	66.2	30.1
+ Items NOT to be Reclassified to P&L	—	—	-0.6	—	—	—	2.1	—	—	—	10.3	—
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.5	—	—	—	2.1	—
+ Tax on Items NOT to be Reclassified — alt tag	—	—	-0.1	—	—	—	—	—	—	—	—	—
+ Items to be Reclassified to P&L	17.5	-6.4	12.5	3.1	3.4	6.7	13.1	18.7	36.4	17.9	49.6	38.1
+ Tax on Items to be Reclassified	—	—	—	—	—	—	4.0	-0.3	-3.1	-0.7	-8.4	8.0
+ Tax on Items to be Reclassified — alt tag	2.0	-1.9	2.7	0.8	-0.3	-3.7	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	117.7	121.1	—	137.0	100.9	128.0	162.6	—	170.1	168.8	—	210.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	4.22	5.18	5.35	5.56	4.01	4.85	6.27	4.64	5.38	6.19	8.23	7.26
Diluted EPS — Continuing Operations	4.22	5.18	5.35	5.55	4.01	4.85	6.27	4.64	5.38	6.19	8.23	7.12
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	614.4	658.3	706.2	695.4	599.4	702.0	759.1	785.0	852.0	886.4	966.5	969.0
Gross Margin %	51.65	56.96	60.06	58.94	62.01	61.71	63.39	64.87	65.69	63.86	65.72	65.61
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	136.0	170.1	175.6	181.4	128.4	152.8	166.8	170.4	175.9	202.2	246.4	240.4
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.0	30.8	-25.9	0.0	0.0	15.9	0.0
Net Income Adj (tax-effected)	102.1	125.7	129.6	134.6	97.2	117.6	128.4	132.8	130.6	150.2	189.3	180.0
EPS Adj	4.22	5.18	5.35	5.56	4.01	4.85	5.29	5.47	5.38	6.19	7.73	7.26
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	24.2	24.2	24.2	24.2	24.2	24.2	24.3	24.3	24.3	24.3	24.8	24.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Granules India Q2 FY27 results date

Granules India (NSE: GRANULES) will announce its Q2 FY27 results (July–September 2026) on Monday, 2 November 2026, according to the board-meeting notice it filed on 23 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹180 crore, up 63.0% from ₹110 crore in Q1 FY26 and down 10.7% from ₹202 crore in Q4 FY26. Revenue from operations was ₹1,477 crore, up 22.0% year on year and up 0.4% from the previous quarter.

Board-meeting notice filed: 23 October 2026
Q2 FY26 results (a year earlier): 13 November 2025
Q1 FY27 results (the latest): 21 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 2 November 2026Monday · notice filed 23 Oct
Q1 FY27 net profit: ₹180 Cr+63.0% vs Q1 FY26−10.7% vs Q4 FY26
Q1 FY27 revenue: ₹1,477 Cr+22.0% vs Q1 FY26+0.4% vs Q4 FY26
Q1 FY27 operating margin: 17.6%+2.9 pts vs Q1 FY26−0.8 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹131 CrRevenue ₹1,297 Cr
Q1 FY27 EPS (basic): ₹7.26

Questions

When will Granules India announce its Q2 FY27 results?

On 2 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 23 October 2026). Last year it reported Q2 FY26 on 13 November 2025.

What will Granules India's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹131 crore and revenue from operations ₹1,297 crore. The latest quarter, Q1 FY27, had a net profit of ₹180 crore and revenue of ₹1,477 crore.

What were Granules India's Q1 FY27 results?

Consolidated net profit was ₹180 crore, up 63.0% from ₹110 crore in Q1 FY26 and down 10.7% from ₹202 crore in Q4 FY26. Revenue from operations was ₹1,477 crore, up 22.0% year on year and up 0.4% from the previous quarter.

How has Granules India's profit changed over the last four quarters?

Net profit by quarter: ₹131 crore in Q2 FY26, ₹150 crore in Q3 FY26, ₹202 crore in Q4 FY26 and ₹180 crore in Q1 FY27. That is ₹662 crore over the four quarters, up 38.8% from ₹477 crore in the four quarters before. Revenue from operations: ₹1,297 crore, ₹1,388 crore, ₹1,471 crore and ₹1,477 crore.

What was Granules India's net profit in FY26?

Consolidated net profit was ₹595 crore in FY26 (April 2025–March 2026), up 18.6% from ₹502 crore in FY25. It was ₹426 crore in FY24 and ₹517 crore in FY23: up 15.2% over three years, 4.8% a year on average.

What was Granules India's revenue in FY26?

Revenue from operations was ₹5,366 crore in FY26 (April 2025–March 2026), up 19.7% from ₹4,482 crore in FY25. It was ₹4,506 crore in FY24 and ₹4,512 crore in FY23: up 18.9% over three years, 5.9% a year on average.

Where do these Granules India figures come from?

From Granules India's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.